Table 1. Open in new tab Baseline...

Table 1.

Baseline Clinical Characteristics

	Total Group	GH/GnRHa	GH	P Value
No.	110	67	43
Boys/girls	51/59	25/42	26/17	.018
Gestational age, wk	37.4 (3.3)	37.4 (3.6)	37.5 (3.0)	.886
Birth weight SDS	−2.0 (1.0)^a	−2.0 (0.9)^a	−2.0 (1.0)^a	.888
Birth length SDS	−2.7 (1.3)^a	−2.8 (1.3)^a	−2.6 (1.2)^a	.513
Target height SDS	−0.7 (0.7)^a	−0.7 (0.7)^a	−0.7 (0.7)^a	.849
Age, y	11.4 (1.5)	11.6 (1.2)	11.0 (1.8)	.065
Height SDS	−2.9 (0.6)^a	−2.9 (0.7)^a	−2.9 (0.6)^a	.591
Body mass index SDS	−1.0 (1.0)	−0.9 (1.0)	−1.2 (1.0)	.202
IGF-I SDS	−1.17 (1.2)	−1.08 (1.1)	−1.30 (1.5)	.374
Prepubertal/pubertal	52/58	19/48	33/10	<.001
Pubertal stage (14)
Tanner 1	52	19	33
Tanner 2	41	36	5
Tanner 3	17	12	5
Fasting glucose, mmol/L	5.0 (0.5)	5.0 (0.5)	4.9 (0.5)	.605
Fasting insulin, mU/L	5.3 (4.8)	6.3 (5.5)	3.8 (3.0)	.406
HOMA-IR	1.2 (1.2)	1.5 (1.4)	0.9 (0.8)	.471

	Total Group	GH/GnRHa	GH	P Value
No.	110	67	43
Boys/girls	51/59	25/42	26/17	.018
Gestational age, wk	37.4 (3.3)	37.4 (3.6)	37.5 (3.0)	.886
Birth weight SDS	−2.0 (1.0)^a	−2.0 (0.9)^a	−2.0 (1.0)^a	.888
Birth length SDS	−2.7 (1.3)^a	−2.8 (1.3)^a	−2.6 (1.2)^a	.513
Target height SDS	−0.7 (0.7)^a	−0.7 (0.7)^a	−0.7 (0.7)^a	.849
Age, y	11.4 (1.5)	11.6 (1.2)	11.0 (1.8)	.065
Height SDS	−2.9 (0.6)^a	−2.9 (0.7)^a	−2.9 (0.6)^a	.591
Body mass index SDS	−1.0 (1.0)	−0.9 (1.0)	−1.2 (1.0)	.202
IGF-I SDS	−1.17 (1.2)	−1.08 (1.1)	−1.30 (1.5)	.374
Prepubertal/pubertal	52/58	19/48	33/10	<.001
Pubertal stage (14)
Tanner 1	52	19	33
Tanner 2	41	36	5
Tanner 3	17	12	5
Fasting glucose, mmol/L	5.0 (0.5)	5.0 (0.5)	4.9 (0.5)	.605
Fasting insulin, mU/L	5.3 (4.8)	6.3 (5.5)	3.8 (3.0)	.406
HOMA-IR	1.2 (1.2)	1.5 (1.4)	0.9 (0.8)	.471

Data are expressed as mean (SDS), unless written otherwise. Fasting insulin and HOMA-IR were square root–transformed before analyses and adjusted for Tanner stage at baseline. Bold text indicates a significant P-value (<.05)

Variables in SDS compared with 0 SDS, P < .01.

This Feature Is Available To Subscribers Only